359 related articles for article (PubMed ID: 19497287)
1. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors.
Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K
Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
[TBL] [Abstract][Full Text] [Related]
3. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
5. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
[TBL] [Abstract][Full Text] [Related]
6. Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline.
Frédérich M; Hayette MP; Tits M; De Mol P; Angenot L
Planta Med; 2001 Aug; 67(6):523-7. PubMed ID: 11509972
[TBL] [Abstract][Full Text] [Related]
7. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro.
Randrianarivelojosia M; Raharimalala LA; Randrianasolo L; Ratsimbasoa A; Rason MA; Ariey F; Jambou R
Ann Trop Med Parasitol; 2001 Apr; 95(3):237-43. PubMed ID: 11339883
[TBL] [Abstract][Full Text] [Related]
8. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
[TBL] [Abstract][Full Text] [Related]
9. Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes.
Baune B; Furlan V; Taburet AM; Farinotti R
Drug Metab Dispos; 1999 May; 27(5):565-8. PubMed ID: 10220483
[TBL] [Abstract][Full Text] [Related]
10. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Plasmodium falciparum to four antimalarial drugs in the Central Province of Papua New Guinea.
Hombhanje FW
P N G Med J; 1998 Jun; 41(2):51-8. PubMed ID: 10934544
[TBL] [Abstract][Full Text] [Related]
12. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
[TBL] [Abstract][Full Text] [Related]
13. Synergism of cimetidine with anti-malarial agents.
Paciorkowski A; Dai WW; Cerami A; Berger BJ
J Parasitol; 1997 Oct; 83(5):960-3. PubMed ID: 9379310
[TBL] [Abstract][Full Text] [Related]
14. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
Nour BY; Faragalla IA; Saeed OK; Mohamadani AA
Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Plasmodium falciparum isolates to chloroquine and mefloquine in southeastern Mindanao Island, the Philippines.
Hatabu T; Kawazu S; Suzuki J; Valenzuela RF; Villacorte EA; Suzuki M; Rivera PT; Kano S
Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):546-51. PubMed ID: 15115125
[TBL] [Abstract][Full Text] [Related]
16. Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
Wurtz N; Briolant S; Gil M; Parquet V; Henry M; Baret E; Amalvict R; Almeras L; Rogier C; Pradines B
J Antimicrob Chemother; 2010 Jul; 65(7):1387-94. PubMed ID: 20501488
[TBL] [Abstract][Full Text] [Related]
17. The in vitro antimalarial interaction of 9-hydroxycalabaxanthone and α-mangostin with mefloquine/artesunate.
Chaijaroenkul W; Na-Bangchang K
Acta Parasitol; 2014 Mar; 60(1):105-11. PubMed ID: 26204026
[TBL] [Abstract][Full Text] [Related]
18. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
[TBL] [Abstract][Full Text] [Related]
19. Study on the biochemical basis of mefloquine resistant Plasmodium falciparum.
Na-Bangchang K; Bray PG; Ward SA
Exp Parasitol; 2007 Oct; 117(2):141-8. PubMed ID: 17570363
[TBL] [Abstract][Full Text] [Related]
20. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
